Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
SunNutraPharm s.r.l., Spin-Off Company of University of Messina, Messina, Italy.
Nat Prod Res. 2024 Feb-Mar;38(5):773-780. doi: 10.1080/14786419.2023.2197598. Epub 2023 Apr 20.
The oral administration is probably the most used and largely applicable method, even if absorption across the intestinal epithelium is a limiting factor that can invalidate the achievement of a therapy. The aim of this study was to assess the steady state bioavailability of very low molecular weight hyaluronic acid (vLMW-HA) and its distribution in different districts of mice. Adult female C57BL6/J mice ( = 26) were divided in three groups and orally treated for 7 days with: saline solution (SHAM-HA), high dose of vLMW-HA (5 kDa; 500 mg/kg/day; HD-vLMW-HA), and low dose of vLMW-HA (5 kDa; 100 mg/kg/day; LD-vLMW-HA). HA content was quantified in plasma, skin, bladder, gut, rectum, vagina, and eyes with ELISA assay at the end of treatment. HA level significantly increased after treatment with HD-vLMW-HA in all analyzed tissues and plasma. Therefore, vLMW-HA easy absorption and distribution after the oral intake opens new possibilities for future biomedical applications.
口服给药可能是最常用且适用范围最广的方法,尽管肠上皮细胞的吸收是一个限制因素,可能会使治疗无效。本研究旨在评估超低分子量透明质酸(vLMW-HA)的稳态生物利用度及其在小鼠不同部位的分布。成年雌性 C57BL6/J 小鼠(n=26)分为三组,连续 7 天口服以下处理:生理盐水(SHAM-HA)、高剂量 vLMW-HA(5 kDa;500 mg/kg/天;HD-vLMW-HA)和低剂量 vLMW-HA(5 kDa;100 mg/kg/天;LD-vLMW-HA)。治疗结束时,通过 ELISA 测定法检测血浆、皮肤、膀胱、肠道、直肠、阴道和眼睛中的 HA 含量。在所有分析的组织和血浆中,HD-vLMW-HA 处理后 HA 水平显著升高。因此,vLMW-HA 经口服摄入后易于吸收和分布,为未来的生物医学应用开辟了新的可能性。